tiprankstipranks
Design Therapeutics (DSGN)
NASDAQ:DSGN
US Market

Design Therapeutics (DSGN) Stock Investors

68 Followers
Based on 728,574 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold DSGN
On average, investors allocate 0.00% of their portfolios to DSGN
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding DSGN

1.3%
Last 7
Days
9.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding DSGN, out of 728,574 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

DSGN Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.04%
$2.88
Based on the activity of 13,682 investors who made their portfolios public
The table shows changes in DSGN in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

DSGN Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
UiPath
3.51%
+0.03%
-1.53%
11.08B
Technology
Marathon Digital Holdings
5.40%
-0.26%
-3.45%
4.28B
Financial
Riot Platforms
4.80%
-1.51%
+0.37%
2.17B
Financial
Coherus Biosciences
2.66%
-1.32%
-8.34%
245.00M
Healthcare
Coinbase Global
8.25%
-0.13%
-2.21%
54.13B
Financial
Airbnb
4.75%
-0.59%
-4.47%
100.72B
Consumer Cyclical
C3ai
5.37%
+0.40%
-3.43%
2.54B
Technology
DraftKings
7.13%
-1.26%
-3.57%
37.89B
Consumer Cyclical
Cisco Systems
4.55%
-0.81%
-5.21%
195.33B
Technology
Block
4.49%
-1.08%
-7.00%
45.25B
Technology
Based on the activity of 728,574 active portfolios
Open your Smart Portfolio

DSGN Investor Analysis

DSGN investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
35.7%
of DSGN holders
are under 35
Average Segment Performance
Average P/E Ratio57.26
Beta6.62
Dividend Yield5.85%
DSGN investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
42.9%
of DSGN holders
are between 35–55
Average Segment Performance
Average P/E Ratio62.56
Beta11.45
Dividend Yield8.22%
DSGN investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
21.4%
of DSGN holders
are over 55
Average Segment Performance
Average P/E Ratio54.63
Beta4.16
Dividend Yield22.09%
Overview of age group and performance of DSGN stock investors
See who invests in DSGN according to age group and performance.

FAQ

How many retail Investors hold DSGN?
<0.1% of TipRanks' retail investors hold DSGN in their portfolios.
    What is DSGN Investor Sentiment?
    DSGN’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of DSGN in the last 7 days?
      ▼ 1.3% of TipRanks' retail investors changed their holding of DSGN in the last 7 days.
        What percentage of retail investors changed their holding of DSGN in the last 30 days?
        ▼ 9.1% of TipRanks' retail investors changed their holding of DSGN in the last 30 days.
          What is the average age of retail investors who hold DSGN?
          The average age of DSGN Holders is between 35–55.
            What other stocks have DSGN investors also bought?
            DSGN Investors also bought PATH, MARA, RIOT, CHRS, COIN, ABNB, AI, DKNG, CSCO, SQ.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              ATECAlphatec Holdings
              CORCencora
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis